Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yoshioki Yamasaki & Masataka Kuwana. (2020) Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease. Expert Review of Clinical Immunology 16:6, pages 547-560.
Read now
Read now
Articles from other publishers (29)
Michael Kreuter, Jürgen Behr, Francesco Bonella, Ulrich Costabel, Alexander Gerber, Okka W. Hamer, Claus Peter Heussel, Danny Jonigk, Andreas Krause, Dirk Koschel, Gabriela Leuschner, Philipp Markart, Dennis Nowak, Michael Pfeifer, Antje Prasse, Julia Wälscher, Hauke Winter & Hans-Joachim Kabitz. (2023) S1-Leitlinie Interdisziplinäre Diagnostik interstitieller Lungenerkrankungen im Erwachsenenalter. Pneumologie 77:05, pages 269-302.
Crossref
Crossref
Aëlle Le Gall, Trieu-Nghi Hoang-Thi, Raphaël Porcher, Bertrand Dunogué, Alice Berezné, Loïc Guillevin, Véronique Le Guern, Pascal Cohen, Benjamin Chaigne, Jonathan London, Matthieu Groh, Romain Paule, Guillaume Chassagnon, Maria Vakalopoulou, Anh-Tuan Dinh-Xuan, Marie Pierre Revel, Luc Mouthon & Alexis Régent. (2023) Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis. Rheumatology.
Crossref
Crossref
Katharina Buschulte, Michael Kreuter, Udo Schneider & Vincent Casteleyn. (2022) „Enthusiast meets the Experienced“: Pneumo meets … RheumatologieEnthusiast meets the experienced: pneumo meets … rheumatology. Zeitschrift für Pneumologie 20:1, pages 20-32.
Crossref
Crossref
Diego Fernández-Lázaro, María Iglesias-Lázaro, Evelina Garrosa, Saray Rodríguez-García, David Jerves Donoso, Eduardo Gutiérrez-Abejón & Conrado Jorge-Finnigan. (2023) Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review. Medicina 59:2, pages 247.
Crossref
Crossref
M.B. Malarvili, Teo Aik Howe, Santheraleka Ramanathan, Mushikiwabeza Alexie & Om Prakash Singh. 2023. Systems and Signal Processing of Capnography as a Diagnostic Tool for Asthma Assessment. Systems and Signal Processing of Capnography as a Diagnostic Tool for Asthma Assessment
1
24
.
Lisa Jungblut, André Euler, Jochen von Spiczak, Thomas Sartoretti, Victor Mergen, Vanessa Englmaier, Anna Landsmann, Carmen-Marina Mihai, Oliver Distler, Hatem Alkadhi, Thomas Frauenfelder & Katharina Martini. (2022) Potential of Photon-Counting Detector CT for Radiation Dose Reduction for the Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis. Investigative Radiology 57:12, pages 773-779.
Crossref
Crossref
Stamatis-Nick C. Liossis & Constantina A. Bounia. (2022) Treating Autoimmune-Related Interstitial Lung Disease With B Cell Depletion. Frontiers in Medicine 9.
Crossref
Crossref
Elena V. Filimonova, Lyubov A. Davydova, Mariana A. Lysenko & Sergey V. Tsarenko. (2022) Interstitial inflammation and pulmonary fibrosis in COVID-19: The potential role of cytostatic therapy for severe lung injury. Respiratory Medicine Case Reports 38, pages 101676.
Crossref
Crossref
Corrado Campochiaro, Cosimo Bruni, Sara Tomassetti, Lorenzo Dagna & Marco Matucci-Cerinic. 2022. The Lung in Autoimmune Diseases. The Lung in Autoimmune Diseases
73
103
.
Anna-Maria Hoffmann-Vold, Elisabeth Bendstrup, Theodoros Dimitroulas, Roger Hesselstrand, Antonio Morais, Ritva Peltomaa, Vanessa Smith, Joep Welling, Madelon C Vonk & Wim A Wuyts. (2021) Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews. Rheumatology 60:12, pages 5601-5609.
Crossref
Crossref
Hans Bastian & Andreas Krause. (2021) Lunge – Interstitielle Lungenerkrankungen in der
Rheumatologie. Aktuelle Rheumatologie 46:06, pages 544-551.
Crossref
Crossref
Barbara Ruaro, Elisa Baratella, Paola Confalonieri, Barbara Wade, Cristina Marrocchio, Pietro Geri, Annalisa Busca, Riccardo Pozzan, Alessia Giovanna Andrisano, Maria Assunta Cova, Marco Confalonieri & Francesco Salton. (2021) High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients. Diagnostics 11:11, pages 1960.
Crossref
Crossref
Katharina Buschulte, Anna-Maria Hoffmann-Vold, Rucsandra Dobrota, Philipp Höger, Andreas Krause & Michael Kreuter. (2021) Therapie von Lungenfibrosen bei rheumatischen Systemerkrankungen (neue Therapien)Treatment of lung fibrosis in systemic rheumatic diseases (new treatment). Zeitschrift für Rheumatologie 80:8, pages 743-754.
Crossref
Crossref
Hakeem Olaosebikan, Olufunke Adeyeye, Richard Akintayo, Akpabio Akpabio, Ajibade Adenitan, Olufemi Adelowo, Olufemi Ojo & Fasan-Odunsi Abimbola. (2020) Connective tissue disease-–associated interstitial lung disease: an underreported cause of interstitial lung disease in Sub-Saharan Africa. Clinical Rheumatology 40:9, pages 3455-3460.
Crossref
Crossref
Vincent Cottin, Sophie Larrieu, Loic Boussel, Salim Si-Mohamed, Fabienne Bazin, Sébastien Marque, Jacques Massol, Françoise Thivolet-Bejui, Lara Chalabreysse, Delphine Maucort-Boulch, Stéphane Jouneau, Eric Hachulla, Julien Chollet & Mouhamad Nasser. (2021) Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France. Frontiers in Medicine 8.
Crossref
Crossref
Xinyu Ma, Rui Tang, Mei Luo, Zhuotong Zeng, Yaqian Shi, Bingsi Tang & Rong Xiao. (2021) Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis. Clinical Rheumatology 40:8, pages 3185-3193.
Crossref
Crossref
David Roofeh, Celia J. F. Lin, Jonathan Goldin, Grace Hyun Kim, Daniel E. Furst, Christopher P. Denton, Suiyuan Huang & Dinesh Khanna. (2021) Tocilizumab Prevents Progression of Early Systemic Sclerosis–Associated Interstitial Lung Disease. Arthritis & Rheumatology 73:7, pages 1301-1310.
Crossref
Crossref
Qiang Li, Laura Wallace, Padmaja Patnaik, Margarida Alves, Martina Gahlemann, Veronika Kohlbrenner, Christina Raabe, Jocelyn R Wang & Elizabeth M Garry. (2021) Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study. Rheumatology 60:4, pages 1915-1925.
Crossref
Crossref
Madelon C. Vonk, Ulrich A. Walker, Elizabeth R. Volkmann, Michael Kreuter, Sindhu R. Johnson & Yannick Allanore. (2021) Natural variability in the disease course of SSc-ILD: implications for treatment. European Respiratory Review 30:159, pages 200340.
Crossref
Crossref
Anna-Maria Hoffmann-Vold, Toby M. Maher, Edward E. Philpot, Ali Ashrafzadeh & Oliver Distler. (2021) Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review. ERJ Open Research 7:1, pages 00235-2020.
Crossref
Crossref
Anna-Maria Hoffmann-Vold & Øyvind Molberg. (2020) Detection, screening, and classification of interstitial lung disease in patients with systemic sclerosis. Current Opinion in Rheumatology 32:6, pages 497-504.
Crossref
Crossref
Robert W. Simms. (2020) Expert Perspectives On Clinical Challenges: Expert Perspectives: Challenges in Scleroderma. Arthritis & Rheumatology 72:9, pages 1415-1426.
Crossref
Crossref
Gian Luca Erre, Marco Sebastiani, Maria Antonietta Fenu, Angelo Zinellu, Alberto Floris, Lorenzo Cavagna, Elisabetta Renzoni, Andreina Manfredi, Giuseppe Passiu, Richard John Woodman & Arduino Aleksander Mangoni. (2020) Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis. Journal of Clinical Medicine 9:8, pages 2560.
Crossref
Crossref
Felix Chua, Peter Saunders & Jennifer Mann. (2020) Systemic disease and the lung. Medicine 48:6, pages 381-385.
Crossref
Crossref
Christine Fiddler & Helen Parfrey. (2020) Diffuse parenchymal lung disease. Medicine 48:6, pages 373-380.
Crossref
Crossref
H. Findeisen, H. Grasshoff & G. Riemekasten. (2020) Systemische SkleroseSystemic Sclerosis. rheuma plus 19:3, pages 106-114.
Crossref
Crossref
Jintao Jiang, Fang Wang, Aishu Luo, Shiyu Lin, Xiaoke Feng, Wei Yan, Yumeng Shi, Qian Zhang, Xin Gu, Guoliang Cui, Jianan Wang, Lei Wang, Qiande Zhang & Wenfeng Tan. (2020) Polyporus Polysaccharide Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing Myofibroblast Differentiation via TGF-β/Smad2/3 Pathway. Frontiers in Pharmacology 11.
Crossref
Crossref
Susanna Proudman. (2020) Consensus statements for managing systemic sclerosis-associated interstitial lung disease. The Lancet Rheumatology 2:2, pages e64-e65.
Crossref
Crossref
Elena V. Filimonova, Lyubov Davydova, Mariana A. Lysenko & Sergey V. Tsarenko. (2022) Interstitial Inflammation and Pulmonary Fibrosis in COVID-19: The Potential Role of Cytostatic Therapy for Severe Lung Injury. SSRN Electronic Journal.
Crossref
Crossref